Most vaccines have increased efficacy when spreading out the doses, so the same is likely true here, which means this is most likely to increase efficacy.
We don't have data on lots of things, like what if we vaccinated people in cars instead of indoors? We can't run RCTs for everything in this world.
People are also not advocating for 1 dose only, rather spreading the doses out more to get more people vaccinated faster.
1 dose first, followed by another 12 weeks later is almost certainly going to be highly effective and it's almost certainly going to be safe.
This is also not a binary decision. To let you to 10M people try this regime while watching the data has as close to "only upside" as you can get in medicine.
If the FDA approved Astrazeneca now, and the states focused on getting first doses, we could be done with this pandemic in like 45 days. It's worth taking a tiny amount of risk that this group of 10M might not have effective immunity and need to be revaccinated.
EUA means Emergency Use Authorization. Emergency, yes, that's what Covid is. As such, leadership means taking some calculated risks. What FDA essentially does is "you can't get fired for buying IBM". They stick to "we don't have any data for this and that", "this is what the science shows", and people out there are dying. A perfect demonstration of lack of leadership.
1) For how long
2) How it impacts future vaccination efforts
(As well as a slew of other things)
If it was just #1, I'd be with you. If we give a big chunk of the population a vaccine which lasts 6 months and makes them unimmunizable, we've changed a serious problem into a serious, serious problem.
Is there any scientific basis for this hypothetical?
One mechanism: If you have a vaccine designed to deliver a spike protein (without a virus) surrounded by a carrier. The body learns to destroy the carrier. On future doses, the body recognizes the carrier, and the vaccine is destroyed before the body can react.
Of course, a vaccine with a different carrier won't be affected by this mechanisms, but there are many other mechanisms as well. I'm not an expert, and I don't know all of them. I'm not sure science knows all of them either, for that matter.
There have even been instances of vaccines making diseases worse too (actually, viruses not too dissimilar to COVID19). And there are a bunch of other possibilities.
I'd buy the basic premise of giving each person one dose for giving everyone imperfect immunity if not for these sorts of complications. I'd rather just wait a few more months than risk a small (but definitely non-zero) chance of something really, really bad.
How is that the most reasonable approach? Virtually every vaccine ever discovered provides more immunity on first dose, than the incremental gain on subsequent boosters.
You certainly can't be sure of this, but pre-existing evidence would strongly suggest that this vaccine is subject to the law of diminishing returns. At the end of the day, we're just trying to maximize infections prevented. If the two-dose schedule confers 95% immunity, then as long as we expect over 50% immunity from a single dose, then First Dose First is best policy.
This is not how decision making under uncertainty works. When you don't have rigorous proof of whether something works or doesn't work you have to make educated guesses based on various priors and make the percentage play. You can't refuse to incorporate priors into your decision making just because you don't have a peer reviewed p<0.05 study validating it.
Uncertainty about the result cuts both ways. You can't claim that we can't do X over Y because we don't have rigorous proof that X is better than Y, when we don't have rigorous proof that Y is better than X either. Regardless of what you do you're taking a leap of faith.
> We just don't know and it would be way worse if it turns out we have to re-vaccinate everyone because we were impatient.
If there's probability p that it doesn't work and we have to spend X extra months re-vaccinating everyone that's an expected delay of p * X. But if it does work then not pursuing the single dose strategy will delay the vaccination schedule by X' months also.
If p * X < (1-p) * X' then the former is a perfectly acceptable risk.
Sure, there could be some odd unforeseen effect. If so we'd learn as we go.
> it would be way worse if it turns out we have to re-vaccinate everyone
Worse than 3000 people dying every day? Because of the extra expense of making more doses?
As someone who is an active researcher in this field, I can tell you that this is just not true. The immune system is VERY complex and we know very little about it. We have only had the tools to begin to systematically probe it for a few years.
But I don't think they apply to these rather basic questions about how these mRNA vaccines work.
The theory for how they work is clear, and strongly confirmed by the studies showing 95% effectiveness.
Is there really any reason to think that a booster shot that provides 95% protection when given after 21 days will be damaging after 12 weeks?
Or that when two shots gives 95% immunity, 1 shot might give negative immunity?
This what's being implied by the "you never now, so let's do NOTHING" crowd here!
The cardiologist says, “Well, I’ve identified drugs that have saved the lives of millions of people.” Impressed, the kidnappers turn to the immunologist. “What have you done?” they ask.
The immunologist says, “The thing is, the immune system is very complicated …”
And the cardiologist says, “Just shoot me now.”
From https://www.theatlantic.com/health/archive/2020/08/covid-19-... :)
Now we're distributing the vaccine, but the bottleneck is that we have to keep waiting for rainy days. It's especially bad in Arizona and Nevada. Is your contention that we keep the rainy day requirement? Even when all are scientific and empirical priors tell us that the effect is de minims.
The example is kind of silly, but it makes my point. There's literally countless number of factors that go into any trial. There's no possible way that the way treatment is deployed in the field will exactly match the way it was tested. Yet doctors, scientists and public health experts use judgement and empirical priors to determine when and where we can relax the requirements.
They certainly do. And the FDA, a collection of the leading doctors, scientists, and public health experts, just told you that two doses is the regimen. Is there something that you know that these experts don't?
3-4 weeks are quite short intervals for booster shots, picked because of the urgency of getting results, not because it's optimal from a medical standpoint.
> FDA, a collection of the leading doctors, scientists, and public health experts
FDA is primarily a regulatory bureaucracy, tasked with enforcing federal law in this area. The incentives it is under do not always align with optimizing public health.
As for more general critiques, there’s mountains of evidence that the FDA is too risk averse, even before Covid.
Specific to this instance, this FDA meeting was a formality -- they had already had the data for two weeks to review. The efficacy was well-known. They chose to take a 4-day holiday (Thursday, Friday, Saturday, Sunday).
People don't all of a sudden sign house contracts. They've germinated the idea, spent weeks or months working through the pros and cons, talking to their life partners and family and agent and mortgage broker. The decision is made well in advance of the actual contract signing, and all the red lines are done before you get to the actual meeting to sign on the line. Similarly with the FDA regulators, they weren't meeting to review the data for the first time and come up with a decision on the spot. This was one final step in a very long process.
While nearly ten thousand Americans died, I guess the FDA was “catching up on its sleep”. Eight long days of glorious sleep!
Because if it's over 50%, then the math is very simple. First doses must go first. Here's my simple proposal: I bet you $500 that the first peer-reviewed study to specifically test one-dose mRNA Covid-19 vaccines finds at least 50% effectiveness.
Talk is cheap, and I'm sure you get a lot of upvotes on Reddit and Twitter by sprouting some "Follow the Science" hashtag. But actual people's lives are on the line, so if you won't even risk a little bit of money on your beliefs, stop risking people's lives.
I'm not sure I would describe the FDA as optimistically as you do - they are a collection of federal employees, leaning heavily on private industry expertise to navigate the demands of politicians, the expectations of the public, and needs of businesses.
Experts do not agree.
It's also about giving people a vaccine they can believe in, which allows them to return to some of their normal activities. If everyone is 50% safe, no one has any real expectation that they can take any risks without being infected. If half the people are 95% safe, that half can do more things (travel long distances, go to school) while the unvacccinated half can continue to avoid risks until more vaccine is available.
Exactly how it is rolled out here in Moscow. It has never occurred to me that it's not the one and obvious way.
But yes, the "Sputnik" vaccine has huge problems with giving people something they can believe in. Rolling it out in a "rational" order, as if they actually believe it works, is probably the most city government can do to raise confidence.
The reasonable approach is to be overly cautious. A false sense of security is worse than no security at all.
True. But that isn't what is happening here.
This is more "some level of security which is less than absolute, and unclear what sense of security people will assume they have"
We've seen "false sense of security" arguments used time and time again to oppose partial, imperfect safety interventions (seat belts in cars is a great example).
Citation needed.
I wonder if anything can be deduced given knowledge of the mechanisms these vaccines use compared to other vaccines against other viruses.
I know there are vaccines like for HEP-A that confer immunity for at least 10 years given a single shot, and a 20+ years of immunity if a booster is given in six months.
It appears that the FDA doesn't want to offer any information outside of the studies. This cut in half the number of people who can be protected during this winter's covid season.
Definitely need more data on the single dose approach and if that proves safe enough then providers can go that route. Playing with people's health because we want to go cowboy and extract many doses as possible is irresponsible.
What happens if the single dose approach doesn't work as well as hoped? I wouldn't want to be that guinea pig who thought "I'm protected". How long will it be that all hospitals get the information to go back to the two dose approach. Consistent messaging is key during this pandemic. That alone has been hard enough.
If you give more people a single dose you may be gambling that those people receive sufficient uncertainty, but if you give fewer people two doses you are ALSO GAMBLING with the lives of people who do not receive a vaccine. There is no "safe" option here. You just have to make educated guesses about the probabilities and risks involved instead of pretending that one approach is the "safe, conservative" one.
Besides, right now most countries are having more problems getting immunizations done than getting vaccine supplies.
Broward County, FL just put vaccinations on Eventbrite, as a fast way to get appointments set up.[1]
[1] https://www.theverge.com/2021/1/4/22213307/covid-vaccine-flo...
"240 Israelis found with COVID after vaccination, underscoring need for vigilance"
https://www.timesofisrael.com/240-israelis-diagnosed-after-v...
The same is true for vaccines; we have lots of them and we can make an educated guesses about how new ones work, even if new vaccines may not always behave the same as old ones. When you have to make decisions under uncertainty you can't refuse to incorporate educated guesses just because you don't have rigorous p<0.05 peer-reviewed proof confirming those hypotheses.
And as linked in that post, Moderna's primate study: https://www.nejm.org/doi/full/10.1056/NEJMoa2024671?query=fe...
For starters, we have profound differences in the attack curves between treatment and control group, starting about 14 days after administration of the first dose [1]. I don't have the numbers in front of me, but I'm going to guess the trial size is more than adequately powered to detect differences 27 days out.
All this is exactly as theory would predict. Seroconversion typically takes about two weeks. Once seroconversion happens, immunity lasts years (if not decades), which is why most booster doses are given years apart [2]. And any talk of "full efficacy" is confusing population statistics with individual outcomes. To say that Moderna is ~85% effective after one dose, as it appears to be, is to say that 85% of the population will produce antibodies after a single dose. There is no "partial immunity"--you're immune or you're not.
[1] https://www.ft.com/content/7cebed90-3267-4651-a249-56f5a9ae7...
[2] https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolesc...
Is that true? (I'm not an immunologist; I genuinely have no idea.)
I'd have thought that it was all a statistics game: how many antibodies you have and how fast your white cells can respond to the threat before the virus got a foothold. In that model there is partial immunity: some people would win that race, and some wouldn't.
If I'm wrong about that I'd appreciate a better model. Thanks.
It simply isn't workable to reason from lighter symptoms to "partial immunity." Let's pretend the vaccine didn't exist. Take someone with a mild case of covid. Would you say this person is partially immune? Or consider someone with no symptoms at all--are they completely immune? Since the vast majority of cases are mild or asymptomatic, are you prepared to argue that "immunity" is actually very widespread?
Again, your "some people win the race, some lose" analogy is on the mark. It's pointless to talk about "partial victory"
You've basically answered your own question. At the population level, immunity is probabilistic. At the individual level, it's ~deterministic. Those who are challenged but stay healthy are immune. Those who are challenged but get sick are not immune. If we were to repeat the experiment, the individuals who stay healthy/get sick would largely remain the same. In this ex-post view of things, there's no "in-between." You got sick or you didn't, you're immune or you're not.
From an ex-ante perspective, we would instead try to predict whether a person will get sick or not. The answer to this largely depends on whether the body can generate a response to previously recognized antigens. This again is binary. You have memory B-cells due to primary response or you don't; you're immune or you're not.
These are rDNA Prime/Boost vaccines, which is completely different to the conventional vaccines with the multi-year booster regime.
I agree that the 14 and 27 day attack curves should provide some efficiency data though.
In other words, we basically have NO DATA on single dose schedules for Moderna/Pfizer vaccines. There's too few of them anyway to gain any statistically meaningful insight even if we did follow up on these study participant washouts. This is hydroxychloroquine all over again. When you are looking at inadequate data, you can find all sorts of patterns. It is very rare that such patterns turn out to be real. The most reasonable approach is to assume that there is little to no durable protection from a single dose, just like most prime/boost vaccines.